The COVID-19 pandemic has created difficulties in managing gynecological malignancies, leading to limitations on routine visits, reduced face-to-face appointments, postponements of surgeries and interventions, and necessary adjustments to treatment strategies. Hospitals have been overwhelmed with COVID-19 cases, making resource allocation a focal point. The pandemic significantly impacted the mental well-being of women with gynecological cancers, leading to heightened anxiety, worries about treatment delays, and increased stress, depression, and fear. Strategies to support mental health, such as telehealth-based mental health services offering online therapy and support groups, have proven beneficial. Additionally, incorporating mindfulness techniques and meditation practices into daily routines could assist patients in coping with stress and anxiety, ultimately fostering emotional resilience. The COVID-19 pandemic has complicated the traditional approach to prioritizing cancer treatment based on cancer stage. Certain gynecological cancers and their treatments can weaken patients' immune systems, making them more susceptible to severe COVID-19 complications. Advanced-stage and aggressively growing cancers pose a particular risk, as postponing treatment due to COVID-19 concerns could lead to disease progression and impact treatment success and patient survival. The urgency of therapeutic decisions during the pandemic is influenced by cancer stage and aggressiveness, with advanced and rapidly progressing cancers requiring prompt intervention. Patient age and overall health status also play crucial roles, as younger patients with strong immune systems may tolerate treatment delays better than older patients with underlying health conditions. COVID-19 outbreak has undeniably disrupted traditional approaches to managing gynecological malignancies, but it has also spurred creativity and adaptation. Treatment decisions for gynecological cancer patients must consider age, overall health, and cancer stage. By embracing telemedicine, using risk assessment models, and prioritizing collaborative patient management, a more resilient and patient-centered healthcare system can be developed to address current and future pandemic challenges.